Project Details
Description
IM101-075-020 A Sequential Adaptive Phase II/III Multi-Center, Randomized, Double-Bind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept Versus
Status | Finished |
---|---|
Effective start/end date | 4/23/07 → 7/31/09 |
Funding
- BRISTOL-MYERS SQUIBB COMPANY
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.